Beta Bionics, Inc. (BBNX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
$15.49-8.61%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · BBNX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 127.3 | 100.3 | 65.1 | 12.0 | — |
| Cost of Revenues | 52.7 | 44.7 | 29.2 | 5.7 | — |
| Gross Profit | 74.6 | 55.5 | 35.9 | 6.3 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 42.7 | 34.8 | 26.2 | 17.9 | — |
| Operating Income | (92.6) | (71.7) | (45.3) | (35.9) | — |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | 9.5 | 10.9 | 3.9 | 1.8 | — |
| Other Non-Operating Income / Expenses | 9.5 | (1.5) | (9.5) | (8.2) | — |
| Net Income | |||||
| Net Income | (83.1) | (73.2) | (54.8) | (44.1) | — |
| Per Share | |||||
| Basic EPS | (1.79) | (1.81) | (8.60) | (8.31) | — |
| Diluted EPS | (1.79) | (1.81) | (8.60) | (8.31) | — |
| Revenue per Share | 2.73 | — | — | — | — |
| Basic Weighted Avg Shares | 46.5 | 40.5 | 6.4 | 5.3 | — |
| Diluted Weighted Avg Shares | 46.5 | 40.5 | 6.4 | 5.3 | — |
| Supplemental | |||||
| EBIT | (92.6) | (71.7) | (45.3) | (35.9) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.